Vascular Imaging: The Evolving Role of the Multidisciplinary Team Meeting in Peripheral Vascular Disease

Abstract

This article reviews the importance of preinterventional cross-sectional imaging in the evaluation of peripheral arterial disease, as well as discussing the pros and cons of each imaging modality. The importance of a multidisciplinary team approach is emphasized.

Keywords

interventional radiology - peripheral arterial disease - imaging - computed tomographic angiography - magnetic resonance angiography - multidisciplinary

• References

• 1 Maskell G. Commentary on: does every patient need to be discussed at a multidisciplinary team meeting?. Clin Radiol 2013; 68 (8) 760-761
• 2 Chinai N, Bintcliffe F, Armstrong EM, Teape J, Jones BM, Hosie KB. Does every patient need to be discussed at a multidisciplinary team meeting?. Clin Radiol 2013; 68 (8) 780-784
• 3 Morice M-C, Serruys PW, Kappetein AP , et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121 (24) 2645-2653
• 4 Napoli A, Anzidei M, Zaccagna F , et al. Peripheral arterial occlusive disease: diagnostic performance and effect on therapeutic management of 64-section CT angiography. Radiology 2011; 261 (3) 976-986
• 5 Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med 2010; 153 (5) 325-334
• 6 Kock MC, Dijkshoorn ML, Pattynama PM, Myriam Hunink MG. Multi-detector row computed tomography angiography of peripheral arterial disease. Eur Radiol 2007; 17 (12) 3208-3222
• 7 Leiner T, Kessels AG, Schurink GW , et al. Comparison of contrast-enhanced magnetic resonance angiography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss. Invest Radiol 2004; 39 (7) 435-444
• 8 Layden J, Michaels J, Bermingham S, Higgins B ; Guideline Development Group. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ 2012; 345: e4947
• 9 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG ; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67
• 10 Brogneaux C, Sprynger M, Magnée M, Lancellotti P ; European Society For Cardiology. 2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases [in French]. Rev Med Liege 2012; 67 (11) 560-565
• 11 Hirsch AT, Haskal ZJ, Hertzer NR , et al; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)—summary of recommendations. J Vasc Interv Radiol 2006; 17 (9) 1383-1397 , quiz 1398
• 12 Diagnosis and management of peripheral arterial disease. Scottish Intercollegiate Guidelines Network National Clinical Guideline 89, 2006 . Available at: http://www.sign.ac.uk/pdf/sign89.pdf . Accessed June 10, 2014
• 13 Roditi G, Kusumawidjaja D. Magnetic resonance angiography and computed tomography angiography for peripheral arterial disease. Br Inst Radiology 2009; 21 (2) 85-108
• 14 Pollak AW, Norton PT, Kramer CM. Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions. Circ Cardiovasc Imaging 2012; 5 (6) 797-807
• 15 Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356 (9234) 1000-1001
• 16 Grobner T. Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 2006; 21 (4) 1104-1108
• 17 Cowper SE. Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium. Adv Dermatol 2007; 23: 131-154
• 18 Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007; 242 (3) 647-649
• 19 Collidge TA, Thomson PC, Mark PB , et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007; 245 (1) 168-175
• 20 Sadowski EA, Bennett LK, Chan MR , et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243 (1) 148-157
• 21 Roditi G. MRI contrast agent safety in renal impairment. Clin Risk 2009; 15 (2) 47
• 22 Gerretsen SC, le Maire TF, Miller S , et al. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries. Radiology 2010; 255 (3) 988-1000
• 23 Zou Z, Zhang HL, Roditi GH, Leiner T, Kucharczyk W, Prince MR. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 2011; 4 (11) 1206-1216
• 24 Christie A, Chandramohan S, Roditi G. Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: Initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium. Clin Radiol 2013; 68 (2) 125-130
• 25 Trost DW, Zhang HL, Prince MR , et al. Three-dimensional MR angiography in imaging platinum alloy stents. J Magn Reson Imaging 2004; 20 (6) 975-980
• 26 Winklehner A, Karlo C, Puippe G , et al. Raw data-based iterative reconstruction in body CTA: evaluation of radiation dose saving potential. Eur Radiol 2011; 21 (12) 2521-2526
• 27 Collins R, Cranny G, Burch J , et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007; 11 (20) iii-iv , xi–xiii, 1–184
• 28 Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31 (1, Pt 2): S1-S296
• 29 Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011; 53 (6) 1728-1737
• 30 Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003; 38 (2) 272-278
• 31 Jeffcoate WJ, Margolis DJ. Incidence of major amputation for diabetes in Scotland sets a target for us all. Diabetes Care 2012; 35 (12) 2419-2420
• 32 Krishnan S, Nash F, Baker N, Fowler D, Rayman G. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008; 31 (1) 99-101
• 33 Owen AR, Robertson IR, Annamalai G , et al. Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography. J Vasc Interv Radiol 2009; 20 (2) 165-172